What percentage of patients is required to be enrolled in clinical trials according to Standard 1.9?

Standard 1.9 of the Commission on Cancer (CoC) recognizes that the requirements for patient enrollment in clinical trials can differ based on the type of cancer program or facility. Enrolling a specific percentage of patients does not apply universally across all types of cancer programs; instead, it is tailored to the specific program category and its resources. This flexibility allows institutions to align their clinical trial enrollment efforts with their patient demographics, the nature of the cancer treatments they offer, and their overall research capabilities.

It’s important for cancer programs to contribute to clinical research by encouraging patient participation in clinical trials, but the precise percentage of patients that should be enrolled is dictated by particular goals and compliance needs associated with their program category. This standard emphasizes the importance of context in understanding patient enrollment in clinical trials rather than adhering to a set numerical value.